Skip to main content
. 2022 Aug 3;2022(8):CD000160. doi: 10.1002/14651858.CD000160.pub4

Mannheim 2005.

Study characteristics
Methods Allocation concealment: sealed envelopes
Blinding of outcome assessment: duplex and clinical FU blinding unknown
Cross‐overs: none
Exclusions during trial: none
Participants lost to FU: unknown
Participants Country: Israel
Number of participants: 404
Number of operations: 422
Sex: 65.6% male
Mean age: 69.5 years
% asymptomatic carotid disease: 53.7%
% stenosis: unknown
Comparability: sex, vascular risk factors and % asymptomatic disease similar in each group
Interventions Treatment: polyester urethane patch angioplasty
Control: primary closure
Indication for shunt: change in neurological status during carotid clamping or in participants in general anaesthesia with stump pressure < 40 mmHg
Medication: unknown
Outcomes Death within 30 days and during FU; stroke within 30 days and during FU; coronary event; wound haemorrhage, infection or cranial nerve palsy; restenosis > 50% or occlusion at end of FU (duplex)
Notes Exclusion criteria: small ICA diameter or need for interposition graft
FU: 5 years
Funding sources: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Random sequence generation not reported.
Allocation concealment (selection bias) Low risk Sealed envelopes.
Blinding of participants and personnel (performance bias)
All outcomes High risk Blinding of study participants not reported. Because of the nature of the intervention (patch or primary closure), the surgeon could not be blinded.
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Blinding of outcome assessment not reported.
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Number of participants lost to follow‐up not reported.
Selective reporting (reporting bias) Unclear risk Unclear whether study authors reported the results of all prestated outcomes.
Other bias Low risk None suspected.